Compliance with AZT treatment regimen of HIV-seropositive injection drug users: A neglected issue

AIDS Education and Prevention

Volumn 8, Issue 1, 1996, Pages 58-71

  Freeman, Robert C ^a,b   Rodriguez, Gloria M ^a   French, John F ^a  

^a Drug Abuse and Addiction Services   (United States)

^b NOVA Research Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; PATIENT COMPLIANCE; REVIEW; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIVIRAL AGENTS; ATTITUDE TO HEALTH; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; RESEARCH; SAMPLE SIZE; SAMPLING STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; ZIDOVUDINE;

EID: 0029874611     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Becker, M. H., Maiman, L. A., Kirscht, J. P., Haefner, D. P., Drachman, R. H., & Taylor, D. W. (1979). Patient perceptions and compliance: Recent studies of the health belief model. In R. Brian Haynes, D. Wayne Taylor, and David L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press.
2. Sensing, J. (1991). Doctor-patient communication and the quality of care. Social Science and Medicine, 32, 1301-1310.
3. Blackwell, B. (1979). The drug regimen and treatment compliance. In R. Brian Haynes, D. Wayne Taylor, and David L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press.
4. Bourne, P. G., Alford, J. A., & Bowcock, J. Z. (1966). Treatment of skid-row alcoholics with disulfiram, Quarterly Journal of Studies on Alcohol, 27, 42-48.
5. Brown, B. S., & Brewster, G. W. (1973). A comparison of addict-clients retained and lost to treatment. International Journal of the Addictions, 8, 421-426.
6. Buira, E., Gatell, J. M., Miro, J. M., Batalla, J., Zamora, L., Mallolas, J., Aznar, E., Soriano, E., & San Miguel, J. G. (1992). Influence of treatment with zidovudine (2DV) on the long-term survival of AIDS patients. Journal of Acquired Immune Deficiency Syndromes, 5, 737-742.
7. Centers for Disease Control (1990). Health beliefs and compliance with prescribed medication for hypertension among black women-New Orleans, 1985-86. Morbidity and Mortality Weekly Report, 39, 701-704.
8. Centers for Disease Control (1993). Mortality and Morbidity Weekly Report, 42, (28), 547-557.
9. Cummings, K. M., Kirscht, J. P., Binder, L. R., & Godley, A. J. (1982). Determinants of drug treatment maintenance among hypertensive persons in inner city Detroit. Public Health Reports, 97, 99-106.
10. Davis, M. S. (1968). Variations in patients' compliance with doctors' advice: An empirical analysis of patterns of communication. American Journal of Public Health, 58, 274-288.
11. Delgado, M., & Humm-Delgado, D. (1982). Natural support systems: Source of strength in Hispanic communities. Social Work, 27, 83-89.
12. El-Sadr, W., & Capps, L. (1992). The challenge of minority recruitment in clinical trials for AIDS. Journal of the American Medical Association, 267, 954-957.
13. Fauci, A. S. (1993). Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science, 262, 1011-1018.
14. Friedman, H. S. (1979). Nonverbal communication between patients and medical practitioners. Journal of Social Issues, 35, 82-99.
15. Fuller, R. K., & Neiderhiser, D. H. (1981). Evaluation and application of a urinary diethylamine method to measure compliance with disulfiram therapy. Journal of Studies on Alcohol, 42, 202-207.
16. Garrity, T. F. (1981). Medical compliance and the clinician-patient relationship: A review. Social Science and Medicine, 15E, 215-222.
17. Gelmon, K., Montaner, J. S. G., Fanning, M., Smith, J. R. M., Falutz, J., Tsoukas, C., Gill, J., Wells, G., O'Shaughnessy, M., Wainberg, M., & Ruedy, J. (1989). Nature, time course and dose dependence of zidovudine-related side effects: Results from the Multicenter Canadian Azidothymidine Trial. AIDS, 3, 555-561.
18. Gerrein, J. R., Rosenberg, C. M., and Manohar, V. (1973). Disulfiram maintenance in outpatient treatment of alcoholism. Archives of General Psychiatry, 28, 798-802.
19. Goldsmith, D. S., Hunt, D. E., Lipton, D. S., & Strug, D. L. (1984). Methadone folklore: Beliefs about side effects and their impact on treatment. Human Organization, 43, 330-340.
20. Gordis, L. (1979). Conceptual and methodologic problems in measuring patient compliance. In R. Brian Haynes, D. Wayne Taylor, & David L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press.
21. Graham, N. M. H., Zeger, S. L., Park, L. P., Vermund, S. H., Detels, R., Rinaldo, C. R., & Phair, J. P. (1992). The effects on survival of early treatment of human immunodeficiency virus infection. New England Journal of Medicine, 326 (16), 1037-1042.
22. Hall, A. L., & Bourne, P. G. (1973). Indigenous therapists in a southern black urban community. Archives of General Psychiatry, 28, 137-142.
23. Hall, J. A., Roter, D. L., & Rand, C. S. (1981). Communication of affect between patient and physician. Journal of Health and Social Behavior, 22, 18-30.
24. Hauser, S. T. (1981). Physician-patient relationships. In E. G. Mishler, L. R. AmaraSingham, S. T. Hauser, R. Liem, S. D. Osheison, & N. E. Waxier, Social contexts of health, illness, and patient care. Cambridge: Cambridge University Press.
25. Haynes, R. B. (1979a). Determinants of compliance: the disease and the mechanics of treatment. In R. Brian Haynes, D. Wayne Taylor, and David L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press.
26. Haynes, R. B. (1979b). Strategies to improve compliance with referrals, appointments, and prescribed medical regimens. In R. Brian Haynes, D. Wayne Taylor, & David L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press.
27. Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979). Compliance in health care. Baltimore: Johns Hopkins University Press.
28. Higginbotham, J. C., Trevino, F. M., & Ray, L. A. (1990). Utilization of curanderos by Mexican-Americans: Prevalence and predictors findings from HHANES 1982-84. American Journal of Public Health, 80 (Supplement), 32-35.
29. Hulka, B. S., Cassel, J. C., Kupper, L. L., & Burdette, J. A. (1976). Communication, compliance, and concordance between physicians and patients with prescribed medications. American Journal of Public Health, 66, 847-853.
30. Hunt, D. E., Lipton, D. S., & Goldsmith, D. S. (1981). Meth and medication: Observations of clinic life. Preliminary Report of the Tri-State Ethnographic Project (TRISEP). Unpublished.
31. Hunt, D. E., Lipton, D. S., Goldsmith, D. S., Strug, D. L., & Spunt, B. (1986). 'It takes your heart': The image of methadone maintenance in the addict world and its effect on recruitment into treatment. International Journal of the Addictions, 20, 1751-1771.
32. Johnson, E. M. (1992). From the Alcohol, Drug Abuse, and Mental Health Administration: Methadone and AZT treatment. Journal of the American Medical Association, 268, 447.
33. Keane, T. M., Foy, D. W., Nunn, B., & Rychtarik, R. G. (1984). Spouse contracting to increase antabuse compliance in alcoholic veterans. Journal of Clinical Psychology, 40, 340-344.
34. Korsch, B. M., & Negrete, V. F. (1972). Doctor-patient communication. Scientific American, 227, 66-74.
35. Lagakos, S., Fischl, M. A., Stein, D. S., Lim, L., & Volberding, P. (1991). Effects of zidovudine therapy in minority and other subpopulations with early HTV infection. Journal of the American Medical Association, 266, 2709-2712.
36. Levy, R. L. (1983). Social support and compliance: A selective review and critique of treatment integrity and outcome measurement. Social Science and Medicine, 17, 1329-1338.
37. Liebson, I., Bigelow, G., & Flamer, R. (1973). Alcoholism among methadone patients: A specific treatment method. American Journal of Psychiatry, 130, 483-485.
38. Ludwig, A. M., Levine, J., & Stark, L. H. (1970). LSD and alcoholism: A clinical study of treatment efficacy. Springfield, IL: Charles C Thomas.
39. Macharia, W. M., Leon, G., Rowe, B. H., Stephenson, B. J., & Haynes, R. B. (1992). An overview of interventions to improve compliance with appointment keeping for medical services. Journal of the American Medical Association, 267, 1813-1817.
40. Mays, V. M., & Cochran, S. D. (1987). Acquired immunodeficiency syndrome and black Americans: Special psychosocial issues. Public Health Reports, 107, 224-231.
41. McIntosh, J. (1974). Processes of communication, information seeking and control associated with cancer: A selective review of the literature. Social Science and Medicine, 8, 167-187.
42. McKinlay, J. B. (1975). Who is really ignorant-physician or patient? Journal of Health and Social Behavior, 16, 3-11.
43. Moore, R. D., Hidalgo, J., Sugland, B. W., & Chaisson, R. E. (1991). Zidovudine and the natural history of the acquired immunodeficiency syndrome. New England Journal of Medicine, 324, 1412-1416.
44. National Research Council Committee on Clinical Evaluation of Narcotic Antagonists (1978). Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Archives of General Psychiatry, 35, 335-340.
45. Phillips, E. L. (1988). Patient compliance: New light on health delivery systems in medicine and psychotherapy. Toronto: Hans Huber.
46. Pratt, L., Seligman, W., & Reader, G. (1957). Physician's views on the level of medical information among patients. American Journal of Public Health, 47, 1277-1283.
47. Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., Jackson, G. G., Durack, D. T., Nusinoff-Lehrman, S., & the AZT Collaborative Working Group (1987). The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine, 317, 192-197.
48. Rosenberg, C. M., Davidson, G. E., & Patch, V. D. (1972). Patterns of drop-outs from a methadone program for narcotic addicts. International Journal of the Addictions, 7, 415-425.
49. Ross, F. M. (1991). Patient compliance-whose responsibility? Social Science and Medicine, 32, 89-94.
50. Sackett, D. L., & Snow, J. C. (1979). The magnitude of compliance and noncompliance. In R. Brian Haynes, D. Wayne Taylor, & David L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press.
51. Samora, J., Saunders, L., & Larson, R. F. (1962). Knowledge about specific diseases in four selected samples. Journal of Health and Human Behavior, 3, 176-185.
52. Samuels, J. E., Hendrix, J., Hilton, M., Marantz, P. R., Sloan, V., & Small, C. B. (1990). Journal of Acquired Immune Deficiency Sydromes, 3, 877-883.
53. Sande, M. A., Carpenter, C. C. J., Cobbs, C. G., Holmes, K. K., Sanford, J. P., for the National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients (1993). Antiretroviral therapy for adult HIV-infected patients: recommendations from a state-of-the-art conference. Journal of the American Medical Association, 270, 2583-2589.
54. Schwartz, E. L., Brechbuhl, A.-B., Kahl, P., Miller, M. A., Selwyn, P. A., & Friedland, G. H. (1992). Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 5, 619-626.
55. Scott, C. S. (1974). Health and healing practices among five ethnic groups in Miami, Florida. Public Health Reports, 89, 524-532.
56. Siegel, K., & Krauss, B. J. (1991). Living with HIV infection: Adaptive tasks of seropositive gay men. Journal of Health and Social Behavior, 32, 17-32.
57. Snow, L. F. (1974). Folk medical beliefs and their implications for care of patients: A review based on studies among black Americans. Annals of Internal Medicine, 81, 82-96.
58. Sudnow, D. (1967). Passing on: The social organization of dying. Englewood Cliffs, NJ: Prentice-Hall.
59. Swanson, C. E., & Cooper, D. A. (1990). Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. AIDS, 4, 749-757.
60. Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Jr., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Murphy, R. L., Hardy, W. D., Soeiro, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hyslop, N. E., Richman, D. D., Valentine, F. T., Corey, L., & the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases (1990). Zidovudine in asymptomatic human immunodeficiency virus infection. New England Journal of Medicine, 322, 941-949.
61. Waitzkin, H., & Stoeckle, J. D. (1976). Information control and the micropolitics of health care: Summary of an ongoing research project. Social Science and Medicine, 10, 263-276.
62. Whitlow, J. (1990). Survival rate improves for women with AIDS. Newark Star-Ledger, September 18.
63. Williams, W. V., & Lee, J. (1975). Methadone maintenance: A comparison of methadone treatment subjects and methadone treatment dropouts. International Journal of the Addictions, 10, 599-608.
64. Zax, M., Marsey, R., & Biggs, C. F. (1961). Demographic characteristics of alcoholic outpatients and the tendency to remain in treatment. Quarterly Journal of Studies on Alcohol, 22, 98-105.